Clinical Pharmacology of Antibody-Drug Conjugates

Antibody-drug conjugates (ADCs) are biopharmaceutical products where a monoclonal antibody is linked to a biologically active drug (a small molecule) forming a conjugate. Since the approval of first ADC (Gemtuzumab ozogamicin (trade name: Mylotarg)) for the treatment of CD33-positive acute myelogeno...

Descripción completa

Detalles Bibliográficos
Autor principal: Mahmood, Iftekhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161445/
https://www.ncbi.nlm.nih.gov/pubmed/34063812
http://dx.doi.org/10.3390/antib10020020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161445/
https://www.ncbi.nlm.nih.gov/pubmed/34063812
http://dx.doi.org/10.3390/antib10020020

Ejemplares similares